On November 21, 2023, Matthew Hill submitted his resignation, effective December 1, 2023, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the ? Company?) in order to pursue other professional endeavors. Mr. Hill acknowledged that his resignation was not the result of any disagreement relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 USD | +5.41% | +31.09% | -17.71% |
Jul. 01 | PDS Biotechnology Corporation(NasdaqCM:PDSB) dropped from Russell 3000E Growth Index | CI |
Jul. 01 | PDS Biotechnology Corporation(NasdaqCM:PDSB) dropped from Russell 2000 Growth Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.71% | 150M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- PDS Biotechnology Corporation Announces Resignation of Matthew Hill as Principal Financial Officer and Principal Accounting Officer, Effective December 1, 2023